focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDVRG.L Regulatory News (DVRG)

  • There is currently no data for DVRG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Skin Trust Club iOS App goes live

26 Apr 2021 07:00

RNS Number : 5085W
Deepverge PLC
26 April 2021
 

26 April 2021

DeepVerge PLC

("DeepVerge" or "the Company")

 

Know the skin you're in!

 

Skin Trust Club iOS App goes live after successful completion of 2,000 Alpha skin tests

 

 

DeepVerge (LSE:DVRG.L), the environmental and life science AI company, announces the Skin Trust Club, iOS Apple app is now available in the App Store for download in UK and Ireland. The world's first personalised beauty experience that analyses each user's unique skin microbiome to offer a detailed skin routine in a way that has not been possible before.

 

The Skin Trust Club (www.skintrustclub.com) offers customised skincare routine derived from a home test kit, lab tested and linked to the subscriber's local environment via a smartphone App that identifies ingredients suited to the subscriber's unique skin microbiome and provides updates in real-time. A new revolutionary approach to individual skin maintenance through personalised skincare routine.

 

Home Test Kit comprises a single swab that maps the skin microbiome delivering a report that produces the most appropriate daily skincare routine based on science, not guesswork. Using real-time air pollution and weather data from the customer's location, the Skin Trust App builds a complete picture of the skin microbiome and the impact of local surroundings.

 

Skin Trust Analysis includes:

· Microbiome identification and quantification of living organisms (bacteria, viruses, bacteriophages, fungi, parasites, etc.) on the skin;

· Skin gene expression analysis to quantify the biological activity of living organisms on the skin;

· Analysis of metabolites in the skin sample;

· Personal genetic analysis - analyse genomic data to understand potential skin concerns and future risks but does not analyse genes to identify inherited diseases.

 

Gerard Brandon, CEO of DeepVerge, commented:

 

"The App Store opens our Skin Trust Club to everyone with an interest in providing greater care and protection for their skin. Being able to identify which products are truly suited to just your skin will empower an informed choice of skincare routine, based on your own microbiome and the environmental impacts of the area in which you live. Powered by Labskin, at the York UK, Laboratories and based on the 95% conversion rate of pre-registration participants in the Skin Trust Club, the app provides broad access and is a major milestone to roll-out of the club, launching just as the additional space has become available to accommodate the immediate demand for home test kits upon request.

 

Access to iOS demo can be found here www.skintrustclub.com/demo/"

 

For further information please contact:

DeepVerge plc

Gerard Brandon, CEO

 

+44 (0) 7340 055 648

SPARK Advisory Partners Limited

(Nominated Adviser)

 

Neil Baldwin/Andrew Emmott

+44 (0) 113 370 8974

Turner Pope Investments (TPI) Limited (Broker)

Andy Thacker/Zoe Alexander

+44 (0) 20 3657 0050

 

About DeepVerge plc (www.deepverge.com)

DeepVerge is an environmental and life science group of companies that develops and applies AI and IoT technology to analytical instruments for the analysis and identification of bacteria, virus and toxins. Utilising artificial intelligent data analytics to scientifically prove the impact of skincare product claims on skin microbiome for most of the top 20 global cosmetic company clients and remotely detect and identify in real-time, dangerous pathogens in wastewater treatment plants, drinking water, rivers, lakes and reservoirs.

 

Labskin (Life Science Division)

Labskin have been pioneering the development of a laboratory grown human skin platform for more than 14 years and is the only commercially available lab-grown full thickness human skin model that naturally mimic the skin's microbiome. With top 20 global consumer health and skincare clients, thousands of industry tests, the good and bad bacteria that naturally exists on human skin is present on Labskin when testing skin care, cosmetics, health care, drug delivery or wound care products. The Labskin test platform and protocols help clients maintain an optimum real-world environment, when testing their new ingredients and existing skincare products, that shows the positive or negative impact on skin's natural microflora.

 

About Reach announcements

Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases such as marketing messages, corporate and product information into the public domain. An RNS Regulatory announcement is required to be notified under the AIM Rules for Companies.

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRABXGDSLGDDGBU
Date   Source Headline
30th Sep 20224:35 pmRNSPrice Monitoring Extension
30th Sep 202211:06 amRNSSecond Price Monitoring Extn
30th Sep 202211:00 amRNSPrice Monitoring Extension
22nd Sep 20227:00 amRNSInterim Results
13th Sep 20227:00 amRNSBlue Carbon Resilience project
5th Aug 20227:00 amRNSTrading Update
1st Aug 20227:00 amRNSModern Water secures £2.1m projects
20th Jul 20221:42 pmRNSResult of AGM
20th Jul 20227:00 amRNSDeepVerge to explore options for Labskin Division
19th Jul 20224:41 pmRNSSecond Price Monitoring Extn
19th Jul 20224:36 pmRNSPrice Monitoring Extension
18th Jul 20227:01 amRNSModern Water monitoring systems deal worth £1.4m
4th Jul 20227:00 amRNSSkin Trust Club - update
30th Jun 20227:00 amRNSModern Water Q2 orders exceed £3m, RPT
27th Jun 202211:50 amRNSNotice of AGM
23rd Jun 20227:12 amRNSFinal Results
13th Jun 20227:00 amRNSNotice of Final Results and Annual Report
1st Jun 20221:36 pmRNSSkin Trust Club wins Best New Disrupter Brand
30th May 20227:00 amRNSTesting Services Framework Ag with Abingdon Health
26th Apr 20227:00 amRNSDeepVerge presents at Global Group Investor Summit
19th Apr 20227:00 amRNSUpdate; Manuf'g Service Agreement with Microsaic
19th Apr 20227:00 amRNSHolding(s) in Company
29th Mar 20227:00 amRNSMoU with Abingdon Health for lateral flow tests
28th Mar 20227:00 amRNS1st UK Deployments of Microtox®PD in Wastewater
18th Mar 202211:05 amRNSSecond Price Monitoring Extn
18th Mar 202211:00 amRNSPrice Monitoring Extension
17th Mar 202210:59 amRNSDirector Dealing
17th Mar 20227:00 amRNSAcquisition; Loan Facility for global expansion
11th Mar 20229:05 amRNSSecond Price Monitoring Extn
11th Mar 20229:00 amRNSPrice Monitoring Extension
11th Mar 20227:00 amRNSDeepVerge Q1 production orders up 39% to £5m
21st Feb 20227:00 amRNS82% of Skin Trust Club members purchase via App
19th Jan 20227:00 amRNSMicrotoxPD detects 3 COVID variants of concern
17th Jan 202211:05 amRNSSecond Price Monitoring Extn
17th Jan 202211:00 amRNSPrice Monitoring Extension
11th Jan 20227:00 amRNSTrading Update
6th Jan 20227:00 amRNSMicrotox CTM installed ahead of Winter Olympics
13th Dec 20217:00 amRNSAmends to Agreement with Microsaic Systems; RPT
10th Dec 20219:00 amRNSPrice Monitoring Extension
10th Dec 20217:00 amRNSCompact Microtox® PD launch scheduled for Q1 2022
9th Dec 20214:41 pmRNSSecond Price Monitoring Extn
9th Dec 20214:36 pmRNSPrice Monitoring Extension
26th Nov 20217:00 amRNSRelated Party Transaction
11th Nov 20217:00 amRNSU.S. launch of Skin Trust Club at Beauty Connect
4th Nov 20218:00 amRNSPDMR Dealing
4th Nov 20217:00 amRNSGrant supports DeepVerge Centre of Excellence
3rd Nov 20217:00 amRNSConfirmation of Post-Offer Intention Statements
28th Oct 20217:00 amRNSMicrotox® PD installations as part of nat'l trial
21st Oct 20219:05 amRNSSecond Price Monitoring Extn
21st Oct 20219:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.